Published in Br J Ophthalmol on December 01, 1982
Oestrus ovis ophthalmomyiasis acquired in the UK: case report and scanning electron microscopic study. Br J Ophthalmol (1991) 0.96
Red eye: rule out Ophthalmomyiasis too. Indian J Ophthalmol (2013) 0.92
An unexpected foreign body: a case of external opthalmomyiasis. J Accid Emerg Med (1994) 0.75
External ophthalmomyiasis caused by Estrus ovis. Am J Ophthalmol (1977) 1.37
Unusual case of ophthalmomyiasis interna posterior. Am J Ophthalmol (1970) 1.32
Ocular myiasis interna caused by the sheep nasal bot fly (Oestrus ovis L.). S Afr Med J (1970) 1.26
Ophthalmomyiasis caused by the sheep nasal bot, Oestrus ovis (Oestridae) larvae, in the Benghazi area of Eastern Libya. Trans R Soc Trop Med Hyg (1980) 1.12
Larval conjunctivitis in California caused by Oestrus ovis. Calif Med (1969) 1.01
External ophthalmomyiasis in Australia. Med J Aust (1968) 0.91
External ophthalmomyiasis caused by Oestrus ovis in Queensland. Med J Aust (1974) 0.88
Color test for the measurement of antibody to T-strain mycoplasmas. J Bacteriol (1966) 5.61
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A (1996) 4.82
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med (1991) 4.79
Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation. Brain Res (1986) 3.72
The formation and maintenance of the definitive endoderm lineage in the mouse: involvement of HNF3/forkhead proteins. Development (1993) 3.22
Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol (1999) 3.13
Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial. Ophthalmology (2001) 2.83
Protein binding and signaling properties of RIN1 suggest a unique effector function. Proc Natl Acad Sci U S A (1997) 2.43
Flavoproteins of the mitochondrial respiratory chain. Proc Natl Acad Sci U S A (1967) 2.40
Homologous and heterologous passive cutaneous anaphylactic activity of mouse antisera during the course of immunization. Life Sci (1969) 2.20
Do the Framingham Safety Surveys improve injury prevention counseling during pediatric health supervision visits? J Pediatr (1996) 2.15
Residential proximity to industrial sources of air pollution: interrelationships among race, poverty, and age. J Air Waste Manag Assoc (2001) 2.13
Interaction of human apurinic endonuclease and DNA polymerase beta in the base excision repair pathway. Proc Natl Acad Sci U S A (1997) 2.12
Prevalence of antibodies to the hepatitis E virus in pigs from countries where hepatitis E is common or is rare in the human population. J Med Virol (1999) 2.01
Endoresection of choroidal melanoma. Br J Ophthalmol (1998) 2.00
Management of severe odontogenic infections in pregnancy. Aust Dent J (2012) 1.96
Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings. Br J Ophthalmol (2003) 1.93
New surgical approach in the management of pseudophakic malignant glaucoma. Ophthalmology (2001) 1.91
Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc Natl Acad Sci U S A (1998) 1.90
Trends in vitreoretinal surgery at a tertiary referral centre: 1987 to 1996. Br J Ophthalmol (1999) 1.87
Local anaesthesia for vitreoretinal surgery: a case-control study of 200 cases. Eye (Lond) (1998) 1.67
Medical oaths and declarations. BMJ (2001) 1.67
Apolipoprotein E and cognitive performance. Nature (2000) 1.64
Flavoproteins of mitochondrial fatty acid oxidation. Proc Natl Acad Sci U S A (1967) 1.59
Secondary paracentral retinal holes following internal limiting membrane removal. Br J Ophthalmol (2006) 1.59
Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage? Eye (Lond) (2008) 1.58
Visual loss following removal of intraocular silicone oil. Br J Ophthalmol (2005) 1.56
Determinants of visual outcome after pars plana vitrectomy for posteriorly dislocated lens fragments in phacoemulsification. J Cataract Refract Surg (2001) 1.51
A survey of intraocular lens implantation in the United Kingdom. Trans Ophthalmol Soc U K (1985) 1.51
Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study. Br J Ophthalmol (2005) 1.50
Significance of antibody to mycoplasma as measured by metabolic-inhibition techniques. Ann N Y Acad Sci (1967) 1.48
Pupil block glaucoma in phakic and pseudophakic patients after vitrectomy with silicone oil injection. Am J Ophthalmol (2001) 1.45
Intravitreal penetration of teicoplanin. Eye (Lond) (1998) 1.45
Mapping of a gene for autosomal dominant juvenile-onset open-angle glaucoma to chromosome Iq. Am J Hum Genet (1994) 1.44
Peribulbar anaesthesia: failure to abolish the oculocardiac reflex. Eye (Lond) (1992) 1.43
Visualising vitreous through modified trans-scleral illumination by maximising the Tyndall effect. Br J Ophthalmol (2009) 1.42
Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood (2001) 1.42
Dopamine receptors in schizophrenia. Lancet (1995) 1.41
Comparison of extent of sensory block following posterior and subcostal approaches to ultrasound-guided transversus abdominis plane block. Anaesth Intensive Care (2010) 1.41
Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy. Ophthalmology (2007) 1.40
Five-color-based high-information-content fingerprinting of bacterial artificial chromosome clones using type IIS restriction endonucleases. Genomics (2001) 1.40
Pars plana vitrectomy for the treatment of rhegmatogenous retinal detachment uncomplicated by advanced proliferative vitreoretinopathy. Br J Ophthalmol (1993) 1.40
Inhibition by antihistamines of the vascular permeability increase induced by bradykinin. Br J Pharmacol (1968) 1.34
How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology (2001) 1.33
Acute respiratory distress syndrome in pregnancy and the puerperium: causes, courses, and outcomes. Obstet Gynecol (2001) 1.31
Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys (2001) 1.30
Autoradiographic method for isolation of diverse microbial species with unique catabolic traits. Appl Environ Microbiol (1996) 1.30
Enhanced activity of adenine-DNA glycosylase (Myh) by apurinic/apyrimidinic endonuclease (Ape1) in mammalian base excision repair of an A/GO mismatch. Nucleic Acids Res (2001) 1.28
The inhibitory effect of antiallergy drugs on allergen and histamine induced wheal and flare response. J Allergy Clin Immunol (1973) 1.27
Effect of microtubules and intermediate filaments on mitochondrial distribution. J Cell Sci (1983) 1.26
Contact angles of substances used for internal tamponade in retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol (1994) 1.23
Reduced narcotic requirement by clonidine with improved hemodynamic and adrenergic stability in patients undergoing coronary bypass surgery. Anesthesiology (1987) 1.20
Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome. Clin Pharmacol Ther (1993) 1.20
Changes in the retinal inner limiting membrane associated with Valsalva retinopathy. Br J Ophthalmol (2007) 1.18
Heavy tamponade 1: a review of indications, use, and complications. Eye (Lond) (2008) 1.18
Computer automated visual acuity testing for visual screening. Trans Ophthalmol Soc U K (1986) 1.17
Non-isovolumic behavior of the unit cell of skinned striated muscle fibers. J Mol Biol (1976) 1.17
Recovery and identification of adenovirus in infections of infants and children. Bacteriol Rev (1965) 1.17
Tamponade efficiency of perfluorohexyloctane and silicone oil solutions in a model eye chamber. Br J Ophthalmol (2004) 1.16
Hypothalamic-pituitary-adrenal dysfunction in Apoe(-/-) mice: possible role in behavioral and metabolic alterations. J Neurosci (2000) 1.15
Clinicopathological correlation of epiretinal membranes and posterior lens opacification following perfluorohexyloctane tamponade. Br J Ophthalmol (2001) 1.14
Immunologic methods for the identification of cell types. I. Specific antibodies that distinguish between mammary gland epithelial cells and fibroblasts. J Natl Cancer Inst (1976) 1.14
Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group. Ann Oncol (1994) 1.13
Removal of Densiron-68 with a 23-gauge transconjunctival vitrectomy system. Eye (Lond) (2009) 1.13
Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin). Br J Ophthalmol (2006) 1.11
Rashba spin-splitting control at the surface of the topological insulator Bi2Se3. Phys Rev Lett (2011) 1.11
A crosslinguistic PET study of tone perception. J Cogn Neurosci (2000) 1.10
T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy. J Gastrointest Surg (2000) 1.08
Arabidopsis mutants deficient in T-DNA integration. Proc Natl Acad Sci U S A (1995) 1.08
Host gene regulation during coxsackievirus B3 infection in mice: assessment by microarrays. Circ Res (2000) 1.07
Free cytoplasmic Ca2+ concentration oscillations in thapsigargin-treated parotid acinar cells are caffeine- and ryanodine-sensitive. J Biol Chem (1991) 1.07
Are we getting better at treating retinal detachment? Technology, referral pattern or primary care? Eye (Lond) (1997) 1.07
Myopic pre-foveoschisis: an earlier stage of myopic foveoschisis documented by optical coherence tomography. Eye (Lond) (2009) 1.06
A comparison of three minimally invasive cardiac output devices with thermodilution in elective cardiac surgery. Anaesth Intensive Care (2011) 1.05
Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC). Eye (Lond) (2002) 1.05
Effects of varying levels of positive end-expiratory pressure on intracranial pressure and cerebral perfusion pressure. Crit Care Med (1997) 1.05
Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: results of a multicentre prospective study. Eur J Nucl Med Mol Imaging (2008) 1.04
Challenges in ophthalmic pathology: the vitreoretinal membrane biopsy. Eye (Lond) (2000) 1.04
Immediate hypersensitivity reaction to aminophylline. Report of a case with immunologic confirmation by an in vitro procedure. J Allergy Clin Immunol (1971) 1.04
Management of children with cleft lip and palate. Can Med Assoc J (1980) 1.04
Development of a Chinese version of the National Eye Institute Visual Function Questionnaire (CHI-VFQ-25) as a tool to study patients with eye diseases in Hong Kong. Br J Ophthalmol (2009) 1.04
Mouse homocytotropic antibodies. I. Specific differentiation between mouse 7S gamma 1 and mouse reagin-like antibodies. Life Sci (1968) 1.04
Hepatitis type A, B, and non-A non-B in fulminant hepatitis. Gut (1980) 1.03
The amino terminus of bacteriophage lambda integrase is involved in protein-protein interactions during recombination. J Bacteriol (2000) 1.02
Argon laser photocoagulation for the treatment of polypoidal choroidal vasculopathy. Eye (Lond) (2007) 1.01
Functional heterogeneity of inferior frontal gyrus is shaped by linguistic experience. Brain Lang (2001) 1.00
Laminar connections of the cat's auditory cortex. Brain Res (1981) 1.00
Effect of induced metabolic alkalosis on human skeletal muscle metabolism during exercise. Am J Physiol Endocrinol Metab (2000) 0.99
DNA bending by EcoRI DNA methyltransferase accelerates base flipping but compromises specificity. J Biol Chem (1999) 0.99
Non-vascular vitreoretinopathy: the cells and the cellular basis of contraction. Eye (Lond) (1996) 0.98
Epidemiology and clinical characteristics of acute hepatitis types A, B, and non-A non-B. Scand J Gastroenterol (1979) 0.98
A guide to the removal of heavy silicone oil. Br J Ophthalmol (2008) 0.98
Activation of calcium oscillations by thapsigargin in parotid acinar cells. J Biol Chem (1991) 0.97
Drug carrier systems based on collagen-alginate composite structures for improving the performance of GDNF-secreting HEK293 cells. Biomaterials (2008) 0.97
Calcium oscillations in parotid acinar cells induced by microsomal Ca(2+)-ATPase inhibition. Am J Physiol (1992) 0.97
Denaturing HPLC for high-throughput screening of rifampicin-resistant Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis (2006) 0.97
The influence of explants on the physical efficiency of tamponade agents. Graefes Arch Clin Exp Ophthalmol (1999) 0.97
Developmental expression of proteolipid protein and DM20 mRNAs and proteins in the rat brain. Dev Neurosci (1990) 0.96
Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus. Dis Esophagus (2008) 0.96
Characterization of microbial activities and U reduction in a shallow aquifer contaminated by uranium mill tailings. Microb Ecol (2003) 0.96